Company Filing History:
Years Active: 2001-2006
Title: Peer Mittl: Innovator in Crystallography and Protease Research
Introduction
Peer Mittl is a notable inventor based in Maulburg, Germany. He has made significant contributions to the field of crystallography, particularly in the study of proteases. With a total of 2 patents, his work has implications for drug design and pharmaceutical preparations.
Latest Patents
Mittl's latest patents include groundbreaking inventions in the realm of protease research. The first patent, titled "Crystal structure of cysteine protease," relates to the death protease CPP32 in its crystallized form. This invention not only provides a three-dimensional model of CPP32 but also offers improved methods for designing CPP32 modulators. The second patent, "Transforming growth factor β crystals," concerns TGF-β in a crystalline form that exhibits reduced adsorption to vial walls compared to its soluted counterpart. This crystalline form is more stable against oxidative agents and can be utilized for structure determination, drug design, and the production of slow-release pharmaceutical preparations.
Career Highlights
Throughout his career, Peer Mittl has worked with prominent organizations, including Novartis Corporation and Novartis International AG. His experience in these companies has allowed him to develop and refine his innovative ideas in the field of biochemistry and pharmacology.
Collaborations
Mittl has collaborated with esteemed colleagues such as Markus Grütter and Tudor Arvinte. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Peer Mittl's contributions to the field of crystallography and protease research highlight his innovative spirit and dedication to advancing scientific knowledge. His patents pave the way for future developments in drug design and pharmaceutical applications.